State OK
Clinical Trials in Oklahoma
Recruiting clinical trials with at least one study location in Oklahoma. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oklahoma
Malignant Solid Neoplasm (6)Ovarian Cancer (5)Endometrial Cancer (5)Breast Cancer (4)Colorectal Cancer (4)Melanoma (3)Major Depressive Disorder (3)Anatomic Stage IV Breast Cancer AJCC v8 (3)Clinical Stage III Gastric Cancer AJCC v8 (3)Clinical Stage IV Gastric Cancer AJCC v8 (3)Lung Non-Small Cell Carcinoma (2)Sarcoma (2)
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05111977 N/A
Recruiting
Gastrointestinal Interoception in Anorexia Nervosa
Condition
Anorexia Nervosa
Enrollment
150 pts
Location
United States
Sponsor
Laureate Institute for Brain R
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT07491653 N/A
Recruiting
Fiber mHealth Intervention for Prediabetes
Condition
Prediabetes
Enrollment
80 pts
Location
United States
Sponsor
University of Oklahoma
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
250 pts
Location
United States
Sponsor
University of California, San
NCT05156983 Phase 3
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Nee...
Condition
Coagulation Disorder
Enrollment
328 pts
Location
United States, Argentina, Austria
Sponsor
Takeda
NCT05677451 Phase 3
Recruiting
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, ...
Condition
Chronic Spontaneous Urticaria
Enrollment
100 pts
Location
United States, Argentina, Canada
Sponsor
Novartis Pharmaceuticals
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
NCT06813820 N/A
Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Condition
Left Ventricle Remodeling
Enrollment
135 pts
Location
United States
Sponsor
BioVentrix
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT06030154 N/A
Recruiting
Amplification of Positivity for Alcohol Use
Condition
Alcohol Use Disorder
Enrollment
100 pts
Location
United States
Sponsor
Laureate Institute for Brain R
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP